We examined the relation between the serum total cholesterol level and the risk of death from stroke during six years of follow-up in 350,977 men, 35 to 57 years of age, who had no history of heart attack and were not currently being treated for diabetes mellitus. The diagnosis of stroke and the type of stroke were obtained from death certificates. Using proportional-hazards regression to control for age, cigarette smoking, diastolic blood pressure, and race or ethnic group, we found that the six-year risk of death from intracranial hemorrhage (International Classification of Diseases, ninth edition [ICD-9], categories 431 and 432) was three times higher in men with serum cholesterol levels under 4.14 mmol per liter (160 mg per deciliter) than in those with higher cholesterol levels (P = 0.05 by omnibus test across five cholesterol levels). On the other hand, a positive association was observed between the serum cholesterol level and death from nonhemorrhagic stroke (P = 0.007). The inverse association of the serum cholesterol level with the risk of death from intracranial hemorrhage was confined to men with diastolic blood pressure greater than or equal to 90 mm Hg, in whom death from intracranial hemorrhage is relatively common. We conclude that there is an inverse relation between the serum cholesterol level and the risk of death from hemorrhagic stroke in middle-aged American men, but that its public health impact is overwhelmed by the positive association of higher serum cholesterol levels with death from nonhemorrhagic stroke and total cardiovascular disease (ICD-9 categories 390 through 459).
Source Information
Division of Epidemiology School of Public Health, University of Minnesota, Minneapolis 55455.
This article has been cited by other articles:
Karki, K., Knight, R. A., Han, Y., Yang, D., Zhang, J., Ledbetter, K. A., Chopp, M., Seyfried, D. M.
(2009). Simvastatin and Atorvastatin Improve Neurological Outcome After Experimental Intracerebral Hemorrhage. Stroke
40: 3384-3389
[Abstract][Full Text]
Kim, B. J., Lee, S.-H., Ryu, W.-S., Kang, B. S., Kim, C. K., Yoon, B.-W.
(2009). Low Level of Low-Density Lipoprotein Cholesterol Increases Hemorrhagic Transformation in Large Artery Atherothrombosis but Not in Cardioembolism. Stroke
40: 1627-1632
[Abstract][Full Text]
Ramirez-Moreno, J. M., Casado-Naranjo, I., Portilla, J. C., Calle, M. L., Tena, D., Falcon, A., Serrano, A.
(2009). Serum Cholesterol LDL and 90-Day Mortality in Patients With Intracerebral Hemorrhage. Stroke
40: 1917-1920
[Abstract][Full Text]
Goldstein, L. B.
(2009). The Complex Relationship Between Cholesterol and Brain Hemorrhage. Circulation
119: 2131-2133
[Full Text]
Noda, H., Iso, H., Irie, F., Sairenchi, T., Ohtaka, E., Doi, M., Izumi, Y., Ohta, H.
(2009). Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study. Circulation
119: 2136-2145
[Abstract][Full Text]
Sacco, S., Marini, C., Toni, D., Olivieri, L., Carolei, A.
(2009). Incidence and 10-Year Survival of Intracerebral Hemorrhage in a Population-Based Registry. Stroke
40: 394-399
[Abstract][Full Text]
Imamura, T., Doi, Y., Arima, H., Yonemoto, K., Hata, J., Kubo, M., Tanizaki, Y., Ibayashi, S., Iida, M., Kiyohara, Y.
(2009). LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study. Stroke
40: 382-388
[Abstract][Full Text]
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., Itakura, H., Kita, T., Kitabatake, A., Nakaya, N., Sakata, T., Shimada, K., Shirato, K., for the JELIS Investigators, Japan,
(2008). Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial. Stroke
39: 2052-2058
[Abstract][Full Text]
Goldstein, L. B., Amarenco, P., Szarek, M., Callahan, A. III, Hennerici, M., Sillesen, H., Zivin, J. A., Welch, K.M.A., On behalf of the SPARCL Investigators,
(2008). Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology
70: 2364-2370
[Abstract][Full Text]
Collino, M., Patel, N. S.A., Thiemermann, C.
(2008). Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury. Ther Adv Cardiovasc Dis
2: 179-197
[Abstract]
Nassief, A., Marsh, J. D.
(2008). Statin Therapy for Stroke Prevention. Stroke
39: 1042-1048
[Abstract][Full Text]
Vergouwen, M. D.I., de Haan, R. J., Vermeulen, M., Roos, Y. B.W.E.M.
(2008). Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease. Stroke
39: 497-502
[Abstract][Full Text]
Air, E. L., Kissela, B. M.
(2007). Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms. Diabetes Care
30: 3131-3140
[Full Text]
Henyan, N. N, Riche, D. M, East, H. E, Gann, P. N
(2007). Impact of Statins on Risk of Stroke: A Meta-Analysis. The Annals of Pharmacotherapy
41: 1937-1945
[Abstract][Full Text]
Khella, S., Bleicher, M. B.
(2007). Stroke and Its Prevention in Chronic Kidney Disease. CJASN
2: 1343-1351
[Abstract][Full Text]
Hozawa, A., Okamura, T., Kadowaki, T., Murakami, Y., Nakamura, K., Hayakawa, T., Kita, Y., Nakamura, Y., Okayama, A., Hirotsugu Ueshima for NIPPON DATA80 Research group,
(2007). Is weak association between cigarette smoking and cardiovascular disease mortality observed in Japan explained by low total cholesterol? NIPPON DATA80. Int J Epidemiol
36: 1060-1067
[Abstract][Full Text]
Sturgeon, J. D., Folsom, A. R., Longstreth, W.T. Jr, Shahar, E., Rosamond, W. D., Cushman, M.
(2007). Risk Factors for Intracerebral Hemorrhage in a Pooled Prospective Study. Stroke
38: 2718-2725
[Abstract][Full Text]
Olsen, T. S., Christensen, R. H. B., Kammersgaard, L. P., Andersen, K. K.
(2007). Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality: Ten-Year Follow-Up of Ischemic Strokes in the Copenhagen Stroke Study. Stroke
38: 2646-2651
[Abstract][Full Text]
Fagan, S. C., Elewa, H. F., Rychly, D. J.
(2007). Statin Therapy for Secondary Stroke Prevention: Evidence Catches Up to Practice. Journal of Pharmacy Practice
20: 117-122
[Abstract]
Bang, O. Y., Saver, J. L., Liebeskind, D. S., Starkman, S., Villablanca, P., Salamon, N., Buck, B., Ali, L., Restrepo, L., Vinuela, F., Duckwiler, G., Jahan, R., Razinia, T., Ovbiagele, B.
(2007). Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology
68: 737-742
[Abstract][Full Text]
Patel, T. N., Shishehbor, M. H., Bhatt, D. L.
(2007). A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis. Eur Heart J
28: 664-672
[Abstract][Full Text]
Kurth, T., Everett, B. M., Buring, J. E., Kase, C. S., Ridker, P. M., Gaziano, J. M.
(2007). Lipid levels and the risk of ischemic stroke in women. Neurology
68: 556-562
[Abstract][Full Text]
Everett, B. M., Kurth, T., Buring, J. E., Ridker, P. M.
(2006). The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women. J Am Coll Cardiol
48: 2235-2242
[Abstract][Full Text]
Waters, D. D., LaRosa, J. C., Barter, P., Fruchart, J.-C., Gotto, A. M. Jr, Carter, R., Breazna, A., Kastelein, J. J.P., Grundy, S. M.
(2006). Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study. J Am Coll Cardiol
48: 1793-1799
[Abstract][Full Text]
Jacobson, T. A.
(2006). The Safety of Aggressive Statin Therapy: How Much Can Low-Density Lipoprotein Cholesterol Be Lowered?. Mayo Clin Proc.
81: 1225-1231
[Abstract][Full Text]
The Stroke Prevention by Aggressive Reduction in C,
(2006). High-Dose Atorvastatin after Stroke or Transient Ischemic Attack. NEJM
355: 549-559
[Abstract][Full Text]
Ebrahim, S., Sung, J., Song, Y.-M., Ferrer, R. L, Lawlor, D. A, Smith, G. D.
(2006). Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ
333: 22-
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Circulation
113: e873-e923
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Alberts, M. J., Appel, L. J., Brass, L. M., Bushnell, C. D., Culebras, A., DeGraba, T. J., Gorelick, P. B., Guyton, J. R., Hart, R. G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R. L.
(2006). Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.. Stroke
37: 1583-1633
[Abstract][Full Text]
Koennecke, H.-C.
(2006). Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications. Neurology
66: 165-171
[Abstract][Full Text]
Feigin, V. L., Rinkel, G. J.E., Lawes, C. M.M., Algra, A., Bennett, D. A., van Gijn, J., Anderson, C. S.
(2005). Risk Factors for Subarachnoid Hemorrhage: An Updated Systematic Review of Epidemiological Studies. Stroke
36: 2773-2780
[Abstract][Full Text]
Asia Pacific Cohort Studies Collaboration,
(2005). Joint Effects of Systolic Blood Pressure and Serum Cholesterol on Cardiovascular Disease in the Asia Pacific Region. Circulation
112: 3384-3390
[Abstract][Full Text]
Fletcher, B., Berra, K., Ades, P., Braun, L. T., Burke, L. E., Durstine, J. L., Fair, J. M., Fletcher, G. F., Goff, D., Hayman, L. L., Hiatt, W. R., Miller, N. H., Krauss, R., Kris-Etherton, P., Stone, N., Wilterdink, J., Winston, M.
(2005). Managing Abnormal Blood Lipids: A Collaborative Approach. Circulation
112: 3184-3209
[Abstract][Full Text]
Roquer, J., Campello, A. R., Gomis, M., Ois, A., Munteis, E., Bohm, P.
(2005). Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology
65: 1198-1202
[Abstract][Full Text]
Patel, A., Woodward, M., Campbell, D. J., Sullivan, D. R., Colman, S., Chalmers, J., Neal, B., MacMahon, S.
(2005). Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. Eur Heart J
26: 1910-1915
[Abstract][Full Text]
Paraskevas, K. I., Daskalopoulou, S. S., Daskalopoulos, M. E., Liapis, C. D.
(2005). Secondary Prevention of Ischemic Cerebrovascular Disease. What Is the Evidence?. ANGIOLOGY
56: 539-552
[Abstract]
Feigin, V., Parag, V., Lawes, C. M. M., Rodgers, A., Suh, I., Woodward, M., Jamrozik, K., Ueshima, H., on behalf of the Asia Pacific Cohort Studies Colla,
(2005). Smoking and Elevated Blood Pressure Are the Most Important Risk Factors for Subarachnoid Hemorrhage in the Asia-Pacific Region: An Overview of 26 Cohorts Involving 306 620 Participants. Stroke
36: 1360-1365
[Abstract][Full Text]
Cui, R., Iso, H., Toyoshima, H., Date, C., Yamamoto, A., Kikuchi, S., Kondo, T., Watanabe, Y., Koizumi, A., Wada, Y., Inaba, Y., Tamakoshi, A., JACC Study Group,
(2005). Body Mass Index and Mortality From Cardiovascular Disease Among Japanese Men and Women: The JACC Study. Stroke
36: 1377-1382
[Abstract][Full Text]
Manno, E. M., Atkinson, J. L. D., Fulgham, J. R., Wijdicks, E. F. M.
(2005). Emerging Medical and Surgical Management Strategies in the Evaluation and Treatment of Intracerebral Hemorrhage. Mayo Clin Proc.
80: 420-433
[Abstract]
Hankey, G. J.
(2005). Secondary Prevention of Recurrent Stroke. Stroke
36: 218-221
[Full Text]
Sanguigni, V., Ferro, D., Pignatelli, P., Del Ben, M., Nadia, T., Saliola, M., Sorge, R., Violi, F.
(2005). CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol
45: 35-42
[Abstract][Full Text]
Amarenco, P., Labreuche, J., Lavallee, P., Touboul, P.-J.
(2004). Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis. Stroke
35: 2902-2909
[Abstract][Full Text]
Tirschwell, D. L., Smith, N. L., Heckbert, S. R., Lemaitre, R. N., Longstreth, W. T. Jr., Psaty, B. M.
(2004). Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology
63: 1868-1875
[Abstract][Full Text]
Flemming, K. D., Brown, R. D. Jr
(2004). Secondary Prevention Strategies in Ischemic Stroke: Identification and Optimal Management of Modifiable Risk Factors. Mayo Clin Proc.
79: 1330-1340
[Abstract]
Welch, K.M.A.
(2004). Statins for the prevention of cerebrovascular disease: the rationale for robust intervention. Eur Heart J Suppl
6: C34-C42
[Abstract][Full Text]
Amarenco, P., Tonkin, A. M.
(2004). Statins for Stroke Prevention: Disappointment and Hope. Circulation
109: III-44-III-49
[Abstract][Full Text]
Piechowski-Jozwiak, B., Bogousslavsky, J.
(2004). Cholesterol as a Risk Factor for Stroke: The Fugitive?. Stroke
35: 1523-1524
[Full Text]
Halcox, J. P.J., Deanfield, J. E.
(2004). Beyond the Laboratory: Clinical Implications for Statin Pleiotropy. Circulation
109: II-42-II-48
[Abstract][Full Text]
Zuliani, G., Cherubini, A., Atti, A. R., Ble, A., Vavalle, C., Di Todaro, F., Benedetti, C., Volpato, S., Marinescu, M. G., Senin, U., Fellin, R.
(2004). Low Cholesterol Levels Are Associated With Short-Term Mortality in Older Patients With Ischemic Stroke. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
59: M293-M297
[Abstract][Full Text]
Bowman, T. S., Sesso, H. D., Ma, J., Kurth, T., Kase, C. S., Stampfer, M. J., Gaziano, J. M.
(2003). Cholesterol and the Risk of Ischemic Stroke. Stroke
34: 2930-2934
[Abstract][Full Text]
Sauvaget, C., Nagano, J., Allen, N., Grant, E. J, Beral, V.
(2003). Intake of animal products and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Int J Epidemiol
32: 536-543
[Abstract][Full Text]
Fraser, G.
(2003). Commentary: Protection from stroke by eating animal foods? Surely not!. Int J Epidemiol
32: 543-545
[Full Text]
Asia Pacific Cohort Studies Collaboration,
(2003). Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol
32: 563-572
[Abstract][Full Text]
Buckley, B. M
(2003). Review: Lipids and stroke. British Journal of Diabetes & Vascular Disease
3: 170-176
[Abstract]
Martiskainen, M., Pohjasvaara, T., Mikkelsson, J., Mantyla, R., Kunnas, T., Laippala, P., Ilveskoski, E., Kaste, M., Karhunen, P.J., Erkinjuntti, T.
(2003). Fibrinogen Gene Promoter -455 A Allele as a Risk Factor for Lacunar Stroke. Stroke
34: 886-891
[Abstract][Full Text]
Soyama, Y., Miura, K., Morikawa, Y., Nishijo, M., Nakanishi, Y., Naruse, Y., Kagamimori, S., Nakagawa, H.
(2003). High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study. Stroke
34: 863-868
[Abstract][Full Text]
Shahar, E., Chambless, L. E., Rosamond, W. D., Boland, L. L., Ballantyne, C. M., McGovern, P. G., Sharrett, A. R.
(2003). Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke
34: 623-631
[Abstract][Full Text]
Schneider, A. T., Pancioli, A. M., Khoury, J. C., Rademacher, E., Tuchfarber, A., Miller, R., Woo, D., Kissela, B., Broderick, J. P.
(2003). Trends in Community Knowledge of the Warning Signs and Risk Factors for Stroke. JAMA
289: 343-346
[Abstract][Full Text]
Iso, H., Sato, S., Kitamura, A., Naito, Y., Shimamoto, T., Komachi, Y.
(2003). Fat and Protein Intakes and Risk of Intraparenchymal Hemorrhage among Middle-aged Japanese. Am J Epidemiol
157: 32-39
[Abstract][Full Text]
Ohkuma, H., Tabata, H., Suzuki, S., Islam, M. S.
(2003). Risk Factors for Aneurysmal Subarachnoid Hemorrhage in Aomori, Japan. Stroke
34: 96-100
[Abstract][Full Text]
Di Napoli, P., Taccardi, A.A., Oliver, M., De Caterina, R.
(2002). Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J
23: 1908-1921
Lee, S.-H., Bae, H.-J., Yoon, B.-W., Kim, H., Kim, D.-E., Roh, J.-K.
(2002). Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions. Stroke
33: 2845-2849
[Abstract][Full Text]
Gotto, A. M. Jr, Farmer, J. A.
(2002). Reducing the Risk for Stroke in Patients With Myocardial Infarction: A Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Substudy. Circulation
106: 1595-1598
[Full Text]
Waters, D. D., Schwartz, G. G., Olsson, A. G., Zeiher, A., Oliver, M. F., Ganz, P., Ezekowitz, M., Chaitman, B. R., Leslie, S. J., Stern, T., for the MIRACL Study Investigators,
(2002). Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy. Circulation
106: 1690-1695
[Abstract][Full Text]
Straus, S. E., Majumdar, S. R., McAlister, F. A.
(2002). New Evidence for Stroke Prevention: Scientific Review. JAMA
288: 1388-1395
[Abstract][Full Text]
Iso, H., Sato, S., Umemura, U., Kudo, M., Koike, K., Kitamura, A., Imano, H., Okamura, T., Naito, Y., Shimamoto, T.
(2002). Linoleic Acid, Other Fatty Acids, and the Risk of Stroke. Stroke
33: 2086-2093
[Abstract][Full Text]
Horenstein, R. B., Smith, D. E., Mosca, L.
(2002). Cholesterol Predicts Stroke Mortality in the Women's Pooling Project. Stroke
33: 1863-1868
[Abstract][Full Text]
Engstrom, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L., Lindgarde, F.
(2002). Effects of Cholesterol and Inflammation-Sensitive Plasma Proteins on Incidence of Myocardial Infarction and Stroke in Men. Circulation
105: 2632-2637
[Abstract][Full Text]
Smith, L. H., Boutaud, O., Breyer, M., Morrow, J. D., Oates, J. A., Vaughan, D. E.
(2002). Cyclooxygenase-2-Dependent Prostacyclin Formation Is Regulated by Low Density Lipoprotein Cholesterol In Vitro. Arterioscler. Thromb. Vasc. Bio.
22: 983-988
[Abstract][Full Text]
Koren-Morag, N., Tanne, D., Graff, E., Goldbourt, U., for the Bezafibrate Infarction Prevention Study Gr,
(2002). Low- and High-Density Lipoprotein Cholesterol and Ischemic Cerebrovascular Disease: The Bezafibrate Infarction Prevention Registry. Arch Intern Med
162: 993-999
[Abstract][Full Text]
Kreisberg, R. A., Oberman, A.
(2002). Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies. J. Clin. Endocrinol. Metab.
87: 423-437
[Full Text]
Bots, M L, Elwood, P C, Nikitin, Y, Salonen, J T, Freire de Concalves, A, Inzitari, D, Sivenius, J, Benetou, V, Tuomilehto, J, Koudstaal, P J, Grobbee, D E
(2002). Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J. Epidemiol. Community Health
56: i19-24
[Abstract][Full Text]
Chien, K.-L., Sung, F.-C., Hsu, H.-C., Su, T.-C., Lin, R.-S., Lee, Y.-T.
(2002). Apolipoprotein A-I and B and Stroke Events in a Community-Based Cohort in Taiwan: Report of the Chin-Shan Community Cardiovascular Study. Stroke
33: 39-44
[Abstract][Full Text]
Rodriguez, B. L., D'Agostino, R., Abbott, R. D., Kagan, A., Burchfiel, C. M., Yano, K., Ross, G. W., Silbershatz, H., Higgins, M. W., Popper, J., Wolf, P. A., Curb, J. D., Bosworth, H. B.
(2002). Risk of Hospitalized Stroke in Men Enrolled in the Honolulu Heart Program and the Framingham Study: A Comparison of Incidence and Risk Factor Effects * Editorial Comment: A Comparison of Incidence and Risk Factor Effects. Stroke
33: 230-236
[Abstract][Full Text]
Takemoto, M., Liao, J. K.
(2001). Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors. Arterioscler. Thromb. Vasc. Bio.
21: 1712-1719
[Abstract][Full Text]
Rizos, E., Mikhailidis, D. P
(2001). Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?. Cardiovasc Res
52: 199-207
[Abstract][Full Text]
Davidson, M. H.
(2001). Treatment of the Elderly with 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors: Focus on Drug Interactions. J CARDIOVASC PHARMACOL THER
6: 219-229
[Abstract]
Amarenco, P.
(2001). Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction. Neurology
57: S35-44
[Abstract][Full Text]
Sacco, R. L., Benson, R. T., Kargman, D. E., Boden-Albala, B., Tuck, C., Lin, I-F., Cheng, J. F., Paik, M. C., Shea, S., Berglund, L.
(2001). High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly: The Northern Manhattan Stroke Study. JAMA
285: 2729-2735
[Abstract][Full Text]
Qureshi, A. I., Tuhrim, S., Broderick, J. P., Batjer, H. H., Hondo, H., Hanley, D. F.
(2001). Spontaneous Intracerebral Hemorrhage. NEJM
344: 1450-1460
[Full Text]
Iso, H., Stampfer, M. J., Manson, J. E., Rexrode, K., Hu, F. B., Hennekens, C. H., Colditz, G. A., Speizer, F. E., Willett, W. C.
(2001). Prospective Study of Fat and Protein Intake and Risk of Intraparenchymal Hemorrhage in Women. Circulation
103: 856-863
[Abstract][Full Text]
Plutzky, J., Ridker, P. M.
(2001). Statins for Stroke: The Second Story?. Circulation
103: 348-350
[Full Text]
Byington, R. P., Davis, B. R., Plehn, J. F., White, H. D., Baker, J., Cobbe, S. M., Shepherd, J.
(2001). Reduction of Stroke Events With Pravastatin : The Prospective Pravastatin Pooling (PPP) Project. Circulation
103: 387-392
[Abstract][Full Text]
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J., Members,
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Circulation
103: 163-182
[Full Text]
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., Levine, S. R., Mosca, L., Sacco, R. L., Sherman, D. G., Wolf, P. A., del Zoppo, G. J.
(2001). Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association. Stroke
32: 280-299
[Full Text]
Fann, J R, Kukull, W A, Katon, W J, Longstreth, W T Jr
(2000). Physical activity and subarachnoid haemorrhage: a population based case-control study. J. Neurol. Neurosurg. Psychiatry
69: 768-772
[Abstract][Full Text]
Crouse, J. R. III, Furberg, C. D.
(2000). Treatment of Dyslipidemia : Room for Improvement?. Arterioscler. Thromb. Vasc. Bio.
20: 2333-2335
[Full Text]
Forrester, J. S., Bairey-Merz, C. N., Kaul, S.
(2000). The aggressive low density lipoprotein lowering controversy. J Am Coll Cardiol
36: 1419-1425
[Abstract][Full Text]
Tegos, T. J., Kalodiki, E., Daskalopoulou, S.-S., Nicolaides, A. N.
(2000). Stroke: Epidemiology, Clinical Picture, and Risk Factors: Part I of III. ANGIOLOGY
51: 793-808
[Abstract]
Laufs, U., Gertz, K., Huang, P., Nickenig, G., Bohm, M., Dirnagl, U., Endres, M., Vaughan, C. J.
(2000). Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic Mice Editorial Comment. Stroke
31: 2442-2449
[Abstract][Full Text]
White, H. D., Simes, R. J., Anderson, N. E., Hankey, G. J., Watson, J. D.G., Hunt, D., Colquhoun, D. M., Glasziou, P., MacMahon, S., Kirby, A. C., West, M. J., Tonkin, A. M.
(2000). Pravastatin Therapy and the Risk of Stroke. NEJM
343: 317-326
[Abstract][Full Text]
Wannamethee, S. G., Shaper, A. G., Ebrahim, S.
(2000). HDL-Cholesterol, Total Cholesterol, and the Risk of Stroke in Middle-Aged British Men. Stroke
31: 1882-1888
[Abstract][Full Text]
Albucher, J F, Ferrieres, J, Ruidavets, J B, Guiraud-Chaumeil, B, Perret, B P, Chollet, F
(2000). Serum lipids in young patients with ischaemic stroke: a case-control study. J. Neurol. Neurosurg. Psychiatry
69: 29-33
[Abstract][Full Text]
Kumari, M., Marmot, M., Brunner, E.
(2000). Social Determinants of von Willebrand Factor : The Whitehall II Study. Arterioscler. Thromb. Vasc. Bio.
20: 1842-1847
[Abstract][Full Text]
Milionis, H. J, Winder, A. F, Mikhailidis, D. P
(2000). Lipoprotein (a) and stroke. J. Clin. Pathol.
53: 487-496
[Abstract][Full Text]
Kokubo, Y., Chowdhury, A. H., Date, C., Yokoyama, T., Sobue, H., Tanaka, H.
(2000). Age-Dependent Association of Apolipoprotein E Genotypes With Stroke Subtypes in a Japanese Rural Population. Stroke
31: 1299-1306
[Abstract][Full Text]
Previous
